| Product revenue | 2.23M |
| Funded research and development revenue | |
| Total revenue | |
| Cost of product revenue | 774K |
| Funded research and product development | |
| Unfunded research and product development | |
| Total research and product development expenses | 298K |
| Selling, general and administrative expenses | 829K |
| Operating loss | 331K |
| Gain on derivatives | |
| Other (expense) income, net | |
| Loss before income taxes and non-controlling interest | |
| Income tax benefit | -1K |
| Net loss, net of tax | |
| Plus: Net loss attributed to non-controlling interest | |
| Net income (loss) attributed to MTI | 329K |
| Net earnings (loss) per share attributable to MTI (Basic and Diluted) (in dollars per share) | 0.06 |
| Weighted average shares outstanding (Basic and Diluted) (in shares) | |